IBDEI0H5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8290,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,8291,0)
 ;;=362.01^^52^580^32
 ;;^UTILITY(U,$J,358.3,8291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8291,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,8291,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,8291,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,8292,0)
 ;;=362.02^^52^580^72
 ;;^UTILITY(U,$J,358.3,8292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8292,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,8292,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,8292,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,8293,0)
 ;;=362.03^^52^580^64
 ;;^UTILITY(U,$J,358.3,8293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8293,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,8293,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,8293,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,8294,0)
 ;;=362.04^^52^580^61
 ;;^UTILITY(U,$J,358.3,8294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8294,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,8294,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,8294,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,8295,0)
 ;;=362.05^^52^580^62
 ;;^UTILITY(U,$J,358.3,8295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8295,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8295,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,8295,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,8296,0)
 ;;=362.06^^52^580^98
 ;;^UTILITY(U,$J,358.3,8296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8296,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8296,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,8296,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,8297,0)
 ;;=379.27^^52^580^103
 ;;^UTILITY(U,$J,358.3,8297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8297,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,8297,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,8297,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,8298,0)
 ;;=115.02^^52^580^44
 ;;^UTILITY(U,$J,358.3,8298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8298,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,8298,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,8298,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,8299,0)
 ;;=190.5^^52^580^58
 ;;^UTILITY(U,$J,358.3,8299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8299,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,8299,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,8299,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,8300,0)
 ;;=198.4^^52^580^59
 ;;^UTILITY(U,$J,358.3,8300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8300,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,8300,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,8300,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,8301,0)
 ;;=200.00^^52^580^81
 ;;^UTILITY(U,$J,358.3,8301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8301,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,8301,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,8301,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,8302,0)
 ;;=228.03^^52^580^38
 ;;^UTILITY(U,$J,358.3,8302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8302,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,8302,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,8302,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,8303,0)
 ;;=228.09^^52^580^39
 ;;^UTILITY(U,$J,358.3,8303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8303,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,8303,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,8303,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,8304,0)
 ;;=360.00^^52^580^73
 ;;^UTILITY(U,$J,358.3,8304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8304,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
